• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人癌细胞对有机硒化合物的差异凋亡反应。

Differential apoptotic response of human cancer cells to organoselenium compounds.

机构信息

Department of Microbiology and Immunology, Tohoku University Graduate School of Dentistry, 4-1 Seiryo-machi, Aoba-ku, Sendai, 980-8575, Japan.

出版信息

Cancer Chemother Pharmacol. 2010 Aug;66(3):475-84. doi: 10.1007/s00280-009-1183-6. Epub 2009 Nov 26.

DOI:10.1007/s00280-009-1183-6
PMID:19940991
Abstract

PURPOSE

Selenium (Se) compounds are well known to inhibit cell proliferation and induce cell death in human cancer cells. Respective chemical forms of Se are intracellularly metabolized via complicated pathways, which target distinct molecules and exhibit varying degrees of anti-carcinogenicity in different cancer types; however, the precise mechanisms by which Se activates apoptosis remain poorly understood.

METHODS

The effects of Se compounds, Se-methylselenocysteine (MSC), selenomethionine (SeMet), and selenite on cell proliferation, apoptosis and its pathway in established human carcinoma cell lines (HSC-3, -4, A549, and MCF-7) were investigated. Cancer cells were treated with each Se compound during different periods. Cell apoptosis, caspase activity and ER stress markers were analyzed by flow cytometric or immunoblotting analysis, respectively.

RESULTS

We examined four cell lines for their sensitivity to MSC and SeMet in comparison with selenite. SeMet increased apoptotic cells in p53-positive A549 cells, whereas MSC increased apoptotic cells in p53-mutated HSC-3 cells. High activities of caspase-3, -8 and -9 were observed during apoptosis, and a pan-caspase inhibitor, z-VAD-fmk, rescued the cell viability of HSC-3 cells exposed to MSC. In addition, the occurrence of endoplasmic reticulum (ER) stress was suggested by the observation that levels of phosphorylated eIF2alpha and caspase-12 activity are increased in Se-treated cells. Selenite and MSC were accompanied with the concurrent reduction of phosphorylated Akt levels, and the inhibitory effects of these Se compounds on vascular endothelial growth factor expression were observed with identical patterns.

CONCLUSION

The present findings demonstrate that Se-induced apoptosis in carcinoma cells is basically a caspase-dependent process involving complicated mechanisms. Activation of both the intrinsic apoptotic pathway and ER stress pathway plays a major and concurrent role, while p53 activation seems to have only a functional role in SeMet.

摘要

目的

硒(Se)化合物已被证实能够抑制人类癌细胞的增殖并诱导细胞死亡。Se 的不同化学形式通过复杂的途径在细胞内代谢,针对不同的分子,并在不同类型的癌症中表现出不同程度的抗癌作用;然而,Se 激活细胞凋亡的确切机制仍知之甚少。

方法

研究了 Se 化合物、硒代蛋氨酸(SeMet)、硒代半胱氨酸(MSC)和亚硒酸钠对已建立的人癌细胞系(HSC-3、-4、A549 和 MCF-7)增殖、凋亡及其途径的影响。在不同时期用各 Se 化合物处理癌细胞。通过流式细胞术或免疫印迹分析分别分析细胞凋亡、半胱天冬酶活性和内质网应激标志物。

结果

我们比较了 SeMet 和 MSC 对 p53 阳性 A549 细胞和 p53 突变的 HSC-3 细胞的敏感性,发现 SeMet 增加了 p53 阳性 A549 细胞中的凋亡细胞,而 MSC 增加了 p53 突变的 HSC-3 细胞中的凋亡细胞。凋亡过程中观察到 caspase-3、-8 和 -9 的高活性,pan-caspase 抑制剂 z-VAD-fmk 挽救了暴露于 MSC 的 HSC-3 细胞的细胞活力。此外,通过观察到 Se 处理细胞中磷酸化 eIF2alpha 水平和 caspase-12 活性增加,表明内质网(ER)应激的发生。亚硒酸钠和 MSC 伴随着磷酸化 Akt 水平的同时降低,并且观察到这些 Se 化合物对血管内皮生长因子表达的抑制作用具有相同的模式。

结论

本研究结果表明,Se 诱导的癌细胞凋亡基本上是一个 caspase 依赖性过程,涉及复杂的机制。内源性凋亡途径和 ER 应激途径的激活起着主要和并发的作用,而 p53 激活似乎在 SeMet 中仅具有功能作用。

相似文献

1
Differential apoptotic response of human cancer cells to organoselenium compounds.人癌细胞对有机硒化合物的差异凋亡反应。
Cancer Chemother Pharmacol. 2010 Aug;66(3):475-84. doi: 10.1007/s00280-009-1183-6. Epub 2009 Nov 26.
2
P53-mediated cell cycle arrest and apoptosis through a caspase-3- independent, but caspase-9-dependent pathway in oridonin-treated MCF-7 human breast cancer cells.在冬凌草甲素处理的MCF-7人乳腺癌细胞中,p53通过一条不依赖半胱天冬酶-3但依赖半胱天冬酶-9的途径介导细胞周期停滞和凋亡。
Acta Pharmacol Sin. 2007 Jul;28(7):1057-66. doi: 10.1111/j.1745-7254.2007.00588.x.
3
[Effects of Se-methylselenocysteine on biological behavior of and matrix metalloproteinase-2 expression in human breast cancer MDA-MB-231 cells].[硒代半胱氨酸甲酯对人乳腺癌MDA-MB-231细胞生物学行为及基质金属蛋白酶-2表达的影响]
Ai Zheng. 2008 Feb;27(2):119-25.
4
Indole-3-carbinol induces apoptosis through p53 and activation of caspase-8 pathway in lung cancer A549 cells.吲哚-3-甲醇通过 p53 诱导肺癌 A549 细胞凋亡和激活 caspase-8 途径。
Food Chem Toxicol. 2010 Mar;48(3):883-90. doi: 10.1016/j.fct.2009.12.028. Epub 2010 Jan 6.
5
Mechanisms of clofibrate-induced apoptosis in Yoshida AH-130 hepatoma cells.氯贝丁酯诱导吉田AH - 130肝癌细胞凋亡的机制
Biochem Pharmacol. 2009 Jan 15;77(2):169-76. doi: 10.1016/j.bcp.2008.10.004. Epub 2008 Oct 15.
6
Novel triterpenoid 25-hydroxy-3-oxoolean-12-en-28-oic acid induces growth arrest and apoptosis in breast cancer cells.新型三萜类化合物25-羟基-3-氧代齐墩果-12-烯-28-酸诱导乳腺癌细胞生长停滞和凋亡。
Breast Cancer Res Treat. 2007 Jan;101(1):27-36. doi: 10.1007/s10549-006-9275-z.
7
p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo.p53协同小檗碱诱导人非小细胞肺癌细胞的体外生长抑制和凋亡以及体内肿瘤异种移植生长。
Mol Carcinog. 2009 Jan;48(1):24-37. doi: 10.1002/mc.20453.
8
Selenium compounds regulate p53 by common and distinctive mechanisms.硒化合物通过共同且独特的机制调节p53。
Anticancer Res. 2004 May-Jun;24(3a):1401-8.
9
Exposure of human leukemia NB4 cells to increasing concentrations of selenite switches the signaling from pro-survival to pro-apoptosis.将人类白血病NB4细胞暴露于浓度不断增加的亚硒酸盐中,会使信号传导从促生存转变为促凋亡。
Ann Hematol. 2009 Aug;88(8):733-42. doi: 10.1007/s00277-008-0676-4. Epub 2009 Jan 20.
10
The mycotoxin Zearalenone induces apoptosis in human hepatocytes (HepG2) via p53-dependent mitochondrial signaling pathway.霉菌毒素玉米赤霉烯酮通过p53依赖的线粒体信号通路诱导人肝细胞(HepG2)凋亡。
Toxicol In Vitro. 2008 Oct;22(7):1671-80. doi: 10.1016/j.tiv.2008.06.016. Epub 2008 Jul 10.

引用本文的文献

1
Redox Balance in Cancer in the Context of Tumor Prevention and Treatment.肿瘤预防与治疗背景下癌症中的氧化还原平衡
Biomedicines. 2025 May 9;13(5):1149. doi: 10.3390/biomedicines13051149.
2
Exploring Selenium-Functionalized Hydroxyapatite Using Organic Selenocystine for Antitumor Applications.利用有机硒代胱氨酸探索用于抗肿瘤应用的硒功能化羟基磷灰石
Materials (Basel). 2025 Feb 26;18(5):1043. doi: 10.3390/ma18051043.
3
Exposure to Selenomethionine and Selenocystine Induces Redox-Mediated ER Stress in Normal Breast Epithelial MCF-10A Cells.
暴露于硒代蛋氨酸和硒代胱氨酸会在正常乳腺上皮MCF-10A细胞中诱导氧化还原介导的内质网应激。
Biol Trace Elem Res. 2025 Mar;203(3):1453-1464. doi: 10.1007/s12011-024-04244-y. Epub 2024 May 22.
4
Seleno-amino Acid Metabolism Reshapes the Tumor Microenvironment: from Cytotoxicity to Immunotherapy.硒代氨基酸代谢重塑肿瘤微环境:从细胞毒性到免疫治疗。
Int J Biol Sci. 2024 May 5;20(7):2779-2789. doi: 10.7150/ijbs.95484. eCollection 2024.
5
Differential Inhibition of Anaplerotic Pyruvate Carboxylation and Glutaminolysis-Fueled Anabolism Underlies Distinct Toxicity of Selenium Agents in Human Lung Cancer.回补性丙酮酸羧化和谷氨酰胺分解驱动的合成代谢的差异抑制是硒剂对人肺癌不同毒性的基础。
Metabolites. 2023 Jun 21;13(7):774. doi: 10.3390/metabo13070774.
6
Selenium-enriched plant foods: Selenium accumulation, speciation, and health functionality.富硒植物性食品:硒的积累、形态及健康功能。
Front Nutr. 2023 Feb 6;9:962312. doi: 10.3389/fnut.2022.962312. eCollection 2022.
7
High-Dose Selenium Induces Ferroptotic Cell Death in Ovarian Cancer.高剂量硒诱导卵巢癌细胞发生铁死亡。
Int J Mol Sci. 2023 Jan 18;24(3):1918. doi: 10.3390/ijms24031918.
8
Down regulation of fatty acid synthase inhibition of PI3K/AKT/mTOR in ovarian cancer cell line by novel organoselenium pseudopeptide.新型有机硒假肽对卵巢癌细胞系中脂肪酸合酶的下调作用及对PI3K/AKT/mTOR的抑制作用
Curr Res Pharmacol Drug Discov. 2022 Oct 19;3:100134. doi: 10.1016/j.crphar.2022.100134. eCollection 2022.
9
Therapeutic Benefits of Selenium in Hematological Malignancies.硒在血液系统恶性肿瘤中的治疗益处。
Int J Mol Sci. 2022 Jul 19;23(14):7972. doi: 10.3390/ijms23147972.
10
Evaluating the cytotoxicity of Ge-Sb-Se chalcogenide glass optical fibres on 3T3 mouse fibroblasts.评估锗锑硒硫属化物玻璃光纤对3T3小鼠成纤维细胞的细胞毒性。
RSC Adv. 2021 Feb 25;11(15):8682-8693. doi: 10.1039/d0ra00353k. eCollection 2021 Feb 23.